Novartis Hits Teva With Another Lotrel Suit
By Ben James · February 14, 2008, 12:00 AM EST
Novartis International AG now has two patent suits pending against generics maker Teva Pharmaceuticals USA Inc. over the blockbuster hypertension drug Lotrel, lodging a new complaint after Teva submitted a bid...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login